We are live on ! Find out more
LSF icon

Laird Superfood

24 hedge funds and large institutions have $851K invested in Laird Superfood in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

91% more capital inflows, than outflows

Capital inflows: $98.7K | Capital outflows: $51.8K

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

4% more funds holding

Funds holding: 23 → 24 (+1)

0.61% more ownership

Funds ownership: 8.23% → 8.84% (+0.61%)

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

LSF Hedge Fund Activity: Q3 2023 in Review

24 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Laird Superfood (LSF) for Q3 2023, worth a combined $851K — up 34% from $634K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new LSF positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $38.6K. The largest seller was Millennium Management, cutting an estimated $35.9K.

  • 24 institutional investors held Laird Superfood (LSF) as of Q3 2023, up from 23 in Q2 2023.
  • Funds reported $851K of Laird Superfood stock for Q3 2023, up 34% quarter-over-quarter.
  • 4 funds opened new Laird Superfood positions in Q3 2023 and 1 closed out, a net change of +3 holders.
  • The largest Laird Superfood buyer in Q3 2023 was Creative Planning, an estimated $38.6K added.
  • The largest Laird Superfood seller in Q3 2023 was Millennium Management, an estimated $35.9K sold.

Based on aggregated 13F filings for Q3 2023.